These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity. Puri RK; Leland P; Obiri NI; Husain SR; Mule J; Pastan I; Kreitman RJ Cell Immunol; 1996 Jul; 171(1):80-6. PubMed ID: 8660841 [TBL] [Abstract][Full Text] [Related]
9. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein. Joshi BH; Leland P; Silber J; Kreitman RJ; Pastan I; Berger M; Puri RK Br J Cancer; 2002 Jan; 86(2):285-91. PubMed ID: 11870521 [TBL] [Abstract][Full Text] [Related]
10. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Husain SR; Obiri NI; Gill P; Zheng T; Pastan I; Debinski W; Puri RK Clin Cancer Res; 1997 Feb; 3(2):151-6. PubMed ID: 9815666 [TBL] [Abstract][Full Text] [Related]
11. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy. Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641 [TBL] [Abstract][Full Text] [Related]
13. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells. Kawakami K; Leland P; Puri RK Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. Husain SR; Puri RK J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884 [TBL] [Abstract][Full Text] [Related]
15. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Cai J; Zheng T; Murphy J; Waters CA; Lin GY; Gill PS Invest New Drugs; 1997; 15(4):279-87. PubMed ID: 9547670 [TBL] [Abstract][Full Text] [Related]
16. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548 [TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527 [TBL] [Abstract][Full Text] [Related]
19. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models. Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]